Mathematical model of brain tumour with glia-neuron interactions and chemotherapy treatment.
暂无分享,去创建一个
Murilo S Baptista | S. R. Lopes | Antonio M Batista | Ricardo L Viana | Fernando S Borges | Sergio R Lopes | M. Baptista | A. Batista | R. Viana | F. Borges | Kelly C Iarosz | Regiane A N Siqueira | K. Iarosz | R. A. N. Siqueira
[1] Nicola Bellomo,et al. A Survey of Models for Tumor-Immune System Dynamics , 1996 .
[2] T. Otis,et al. Glia get excited , 2008, Nature Neuroscience.
[3] M. Roddie,et al. Phase I trial of temozolomide using an extended continuous oral schedule. , 1998, Cancer research.
[4] M. Linskey,et al. Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy , 2011, Neurology.
[5] Frank Nani,et al. A chemotherapy model for the treatment of cancer with metastasis , 2002 .
[6] P. Glees. Neuroglia : morphology and function , 1955 .
[7] Nicola J. Allen,et al. Neuroscience: Glia — more than just brain glue , 2009, Nature.
[8] W. Rzeski,et al. Anticancer agents are potent neurotoxins in vitro and in vivo , 2004, Annals of neurology.
[9] W. Schuette. Treatment of brain metastases from lung cancer: chemotherapy. , 2004, Lung cancer.
[10] H. Sontheimer,et al. Glioma cells release excitotoxic concentrations of glutamate. , 1999, Cancer research.
[11] T. Wheldon. Mathematical models in cancer research , 1988 .
[12] Xihui Gao,et al. Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier. , 2014, Small.
[13] Yongzhen Pei,et al. Extinction and permanence of one-prey multi-predators of Holling type II function response system with impulsive biological control. , 2005, Journal of theoretical biology.
[14] Yuri Kogan,et al. Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics , 2008 .
[15] T. Fukushima,et al. Efficacy of temozolomide treatment in patients with high-grade glioma. , 2009, Anticancer research.
[16] Pier Paolo Delsanto,et al. Nutrient competition as a determinant for cancer growth , 1999 .
[17] V. Tiwari,et al. Modulating the delicate glial–neuronal interactions in neuropathic pain: Promises and potential caveats , 2014, Neuroscience & Biobehavioral Reviews.
[18] N. Shapiro,et al. Tumor growth and chemotherapy: Mathematical methods, computer simulations, and experimental foundations , 1973 .
[19] Johan Pallud,et al. A Tumor Growth Inhibition Model for Low-Grade Glioma Treated with Chemotherapy or Radiotherapy , 2012, Clinical Cancer Research.
[20] J. Dichgans,et al. Chemotherapy‐induced cell death in primary cerebellar granule neurons but not in astrocytes: in vitro paradigm of differential neurotoxicity , 2004, Journal of neurochemistry.
[21] Feng-Yi Yang,et al. Pharmacokinetics of BPA in Gliomas with Ultrasound Induced Blood-Brain Barrier Disruption as Measured by Microdialysis , 2014, PloS one.
[22] N. McGranahan,et al. The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.
[23] M. Weller,et al. New (alternative) temozolomide regimens for the treatment of glioma. , 2009, Neuro-oncology.
[24] Webster K. Cavenee,et al. The 2007 WHO ClassiWcation of Tumours of the Central Nervous System , 2007 .
[25] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[26] U. Linz. Chemotherapy for glioblastoma , 2008, Cancer.
[27] Ü. Langel,et al. Peptide-Based Delivery of Oligonucleotides Across Blood–Brain Barrier Model , 2013, International Journal of Peptide Research and Therapeutics.
[28] S. Shaham. Glia-neuron interactions in nervous system function and development. , 2005, Current topics in developmental biology.
[29] A. Papadimitropoulos,et al. "In vitro" 3D models of tumor-immune system interaction. , 2014, Advanced drug delivery reviews.
[30] K. Fujioka,et al. The effect of PTEN on proliferation and drug-, and radiosensitivity in malignant glioma cells. , 2011, Anticancer research.
[31] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[32] J. Weille. On the Genesis of Neuroblastoma and Glioma , 2014 .
[33] H. I. Freedman,et al. A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy , 2013 .
[34] C. S. Holling,et al. The functional response of predators to prey density and its role in mimicry and population regulation. , 1965 .
[35] Isaac Yang,et al. The role of microglia in central nervous system immunity and glioma immunology , 2010, Journal of Clinical Neuroscience.
[36] W. Hahn,et al. Modelling the molecular circuitry of cancer , 2002, Nature Reviews Cancer.
[37] Harald Sontheimer,et al. A neurocentric perspective on glioma invasion , 2014, Nature Reviews Neuroscience.
[38] J. Spratt,et al. Rates of Growth of Pulmonary Metastases and Host Survival , 1964, Annals of surgery.
[39] S. Chaudhuri,et al. Microglial action in glioma: a boon turns bane. , 2010, Immunology letters.
[40] Ponta Grossa,et al. Model for tumour growth with treatment by continuous and pulsed chemotherapy , 2014 .
[41] Philip Gerlee,et al. The Impact of Phenotypic Switching on Glioblastoma Growth and Invasion , 2012, PLoS Comput. Biol..
[42] A. Meyer-Franke,et al. Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture , 1995, Neuron.
[43] R. Fields. Advances in understanding neuron-glia interactions. , 2005, Neuron glia biology.
[44] H. Friedman,et al. Temozolomide and treatment of malignant glioma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[45] D. F. Andrews,et al. A one-hit model of cell death in inherited neuronal degenerations , 2000, Nature.
[46] Yuji Ikegaya,et al. A Statistical Method of Identifying Interactions in Neuron–Glia Systems Based on Functional Multicell Ca2+ Imaging , 2014, PLoS Comput. Biol..
[47] Frederico A. C. Azevedo,et al. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled‐up primate brain , 2009, The Journal of comparative neurology.
[48] P. Maini,et al. A cellular automaton model for tumour growth in inhomogeneous environment. , 2003, Journal of theoretical biology.
[49] Moustapha Hassan,et al. Cyclophosphamide Pharmacokinetics in Mice: A Comparison Between Retro Orbital Sampling Versus Serial Tail Vein Bleeding , 2008 .
[50] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[51] A. Cianciulli,et al. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[52] Alexandre G. Ciancio,et al. Qualitative analysis of second-order models of tumor-immune system competition , 2008, Math. Comput. Model..
[53] P. Marchetti,et al. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents. , 2009, Anticancer research.
[54] C A Condat,et al. Cancer growth: predictions of a realistic model. , 2008, Physical review. E, Statistical, nonlinear, and soft matter physics.
[55] R. Jenkins,et al. Genetics of adult glioma. , 2012, Cancer genetics.
[56] Kristin R. Swanson,et al. The Evolution of Mathematical Modeling of Glioma Proliferation and Invasion , 2007, Journal of neuropathology and experimental neurology.
[57] S. Willaime-Morawek,et al. A-Disintegrin and Metalloprotease (ADAM) 10 and 17 promote self-renewal of brain tumor sphere forming cells. , 2012, Cancer letters.